These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6625647)

  • 1. Is chemotactic activity of polymorphonuclear leukocytes increased in psoriasis?
    Langner A; Chorzelski TP; Fraczykowska M; Jabłońska S; Symańczyk
    Arch Dermatol Res; 1983; 275(4):226-8. PubMed ID: 6625647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.
    Kawohl G; Szperalski B; Schröder JM; Christophers E
    Br J Dermatol; 1980 Nov; 103(5):527-33. PubMed ID: 7437318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.
    Ternowitz T
    J Am Acad Dermatol; 1986 Dec; 15(6):1191-9. PubMed ID: 3027138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil and monocyte chemotaxis in pustulosis palmo-plantaris and pustular psoriasis.
    Ternowitz T; Thestrup-Pedersen K
    Br J Dermatol; 1985 Nov; 113(5):507-13. PubMed ID: 4063189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Pityrosporum-derived chemoattractant for polymorphonuclear leukocytes of psoriatic patients.
    Bunse T; Mahrle G
    Acta Derm Venereol; 1996 Jan; 76(1):10-2. PubMed ID: 8721481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adherence to human endothelium and plastic of neutrophils from psoriatic patients, and the effects of psoriatic patients' sera on normal neutrophils.
    Majewski S; Jabłonska S; Langner A; Pawinska M; Szmurło A
    Br J Dermatol; 1985 Jun; 112(6):655-62. PubMed ID: 4038367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functions of polymorphonuclear leukocytes emigrating into the skin.
    Csato M; Dobozy A; Raith L; Simon N
    Acta Derm Venereol; 1985; 65(2):106-10. PubMed ID: 2408410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo mobilization of polymorphonuclear leukocytes in psoriasis: relationship to clinical parameters and serum inhibitory factors.
    Tigalonowa M; Glinski W; Jablonska S
    J Invest Dermatol; 1983 Jul; 81(1):6-9. PubMed ID: 6863981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis.
    Lundin A; Håkansson L; Michaëlsson G; Venge P
    Arch Dermatol Res; 1987; 279(6):385-91. PubMed ID: 3674962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil chemotaxis in psoriasis before and after PUVA therapy.
    Guillot B; Guilhou JJ; Vendrel JP; Meynadier J
    Arch Dermatol Res; 1983; 275(1):19-22. PubMed ID: 6847241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokinetic and chemotactic factors in psoriasis scale extracts.
    Dahl MV; Lindroos WE; Nelson RD
    J Invest Dermatol; 1978 Dec; 71(6):402-6. PubMed ID: 722120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian rhythm of the in vivo migration of neutrophils in psoriatic patients.
    Pigatto PD; Radaelli A; Tadini G; Polenghi MM; Brambilla L; Altomare G; Carandente F
    Arch Dermatol Res; 1985; 277(3):185-9. PubMed ID: 4015183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphonuclear leukocyte random migration and chemotaxis in psoriatic and healthy adult smokers and non-smokers.
    Sonnex TS; Carrington P; Norris P; Greaves MW
    Br J Dermatol; 1988 Nov; 119(5):653-9. PubMed ID: 3207619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphonuclear leukocytes in psoriasis.
    Glinski W; Mansbridge J
    Cutis; 1985 May; 35(5):441-2. PubMed ID: 4006509
    [No Abstract]   [Full Text] [Related]  

  • 16. IgA-associated inhibition of polymorphonuclear leukocyte chemotaxis in neutrophilic dermatoses.
    Schröder JM; Szperalski B; Koh CJ; Christophers E
    J Invest Dermatol; 1981 Dec; 77(6):464-8. PubMed ID: 7310170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased chemotactic activity of neutrophil leukocytes in psoriasis.
    Michaëlsson G
    Br J Dermatol; 1980 Oct; 103(4):351-6. PubMed ID: 7437300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasis and leukocyte chemotaxis.
    Tagami H; Iwatsuki K; Takematsu H
    J Invest Dermatol; 1987 Mar; 88(3 Suppl):18s-23s. PubMed ID: 3493302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of chemotaxis of polymorphonuclear leukocytes from lead acid battery workers.
    Governa M; Valentino M; Visona I; Scielso R
    Sci Total Environ; 1988 Jun; 71(3):543-6. PubMed ID: 3406721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate inhibits polymorphonuclear leucocyte chemotaxis in psoriasis.
    Walsdorfer U; Christophers E; Schröder JM
    Br J Dermatol; 1983 Apr; 108(4):451-6. PubMed ID: 6838769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.